Impression Healthcare

  • Ticker:ASX:IHL
  • Sector:Healthcare
  • Industry:Supplies
  • CEO:Joel Latham
  • Founded:2001
Categories:
About Us

Impression Healthcare (ASX:IHL) started life as a manufacturer and supplier of custom-fit mouthguards , and other dental equipment. The Oral devices business continues to show strong revenue growth from all products; including, sports mouthguards for teeth protection and to reduce concussion risk, and sophisticated devices made to combat sleep apnoea, snoring and bruxism.

The other side of the company is a rapidly expanding Medicinal cannabis business with four unique clinical trials in partnership with Swinburne University of Technology, that are complementary to the issues they currently aim to prevent with the range of oral devices.

IHL's cannabinoid drug discovery brand Incannex Pharmaceuticals is a collaboration with an EU-based cannibinoid drug design company named Linnea SA. The EU-based company will serve as IHL's supply partner for the base cannabinoid materials in four novel cannabinoid formulations.

IHL has also secured Australian licenses in place to import, export and distribute cannabis products and access to Cannvalate – the largest network of cannabis medicine prescribers in Australia.

More From Impression Healthcare...
Incannex Enters Into Medicinal Cannabis Oil Supply Agreement
Killer Instinct – Impression Healthcare Partners with ONE Championship
Time to Celebrate – Elixinol Publishes Q2 Results, Partners with PharmaCare and Secures Microencapsulation License
Impression Healthcare Extends Agreement With FiT To Study Concussions
Power Play – Impression Healthcare Announces Appointment of Dr Sud Agarwal
Sleep Tight: Impression Healthcare Trialing Cannabis Based Sleep Apnoea Cure
Cannabis Coup – CEO Bruce Linton Axed from Canopy Growth
Impression Healthcare Enters Dronabinol Product Supply Agreement to Facilitate Sleep Apnoea Trial
Knock Out: Impression Healthcare Partners With Boxing Australia
Pearly Whites: Impression Healthcare Trials CBD for Gingivitis
Load More Results
Investor Presentation

The latest update from the company

Click Here
Stay updated about
this company

Signup to get updates.

Management
Joel Latham
Chief Executive Officer
Joel Latham has more than 13 years’ experience with blue chip firms including Mars Foods, Tabcorp and Philip Morris International. Prior to his appointment to CEO, Latham worked as the General Manager of Impression Healthcare for a three-year period. During this time, he played an instrumental role in the marketing and procurement of multiple revenue-generating opportunities and collaborations, including with Pacific Smiles, the NRL, AFL and the implementation of Gameday’s ambassadorial program.
Alistair Blake
Executive Director
Alistair Blake holds an Advanced Diploma of Dental Prosthetics, as well as having 16 years’ experience working in large-scale commercial dental laboratories across Western Australia and Victoria. Blake was a founder of the Denture Innovations Clinic and Laboratory in 2009—which offered services to dentists and specialists nationwide—leading him to identify a commercial opportunity within the Australian mouthguard market. Blake is also a member of the Australian Institute of Company Directors.
Troy Valentine
Chairman
Troy Valentine is a financial professional with over 23 years’ experience in the world of stockbroking and corporate finance. Valentine brings a broad range of experience and skills related to the management of ASX-listed emerging companies to his role as Chairman. Aside from his work with Impression Healthcare, Valentine is also the Executive Director of a boutique advisory firm, Alignment Capital Pty Ltd.
Dr. Sud Agarwal
Chief Medical Officer
Dr Sud Agarwal is an internationally recognised key opinion leader in the clinical use of medicinal cannabis is the co-founder and chief executive officer of Cannvalate. Agarwal received his medical qualifications in the United Kingdom before immigrating to Australia in 2001. He has since played a key role in the commercialisation, scaling and successfully exiting of three healthcare businesses.